Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Signs Expanded License to OGT Patents

NEW YORK, Oct. 30 (GenomeWeb News) - Amersham PLC has signed an expanded license agreement to Oxford Gene Technologies DNA microarray patents, the company said today.


Oxford Gene Technology is the organization set up to manage the early microarray patents and other intellectual property related to inventions by Oxford University professor Edwin Southern.


The new license gives Amersham the rights to OGT's sequence variation patents, as well as patents the relate to analysis of polynucleotide sequences. The license also gives Amersham the right to sublicense the technology.

The expanded agreement comes in the wake of General Electric's announcement Oct. 10 that it was in the process of acquiring Amersham-a deal that the parties said was partly predicated on the capability of combining the companies' technologies in the nascent area of personalized medicine. (See article in Bioarray News, 10-15-03)


This licensing deal is a move to  facilitate the entry of Amersham's CodeLink microarray technology into the personalized medicine arena, particularly in clinical diagnostics, the company said.


"This relationship with OGT will greatly strengthen our CodeLink bioarray platform and will help position CodeLink as the most advanced technology within the scientific community to enable both research and clinical diagnostic applications. Our ability to sublicense this technology will also enable Amersham to make key partnership decisions, especially in the clinical diagnostic field," William Castell, Chief Executive Amersham, said in a statement. "This agreement now paves the way for Amersham to expand the CodeLink product family and to develop CodeLink as a clinical diagnostic platform."


OGT is meanwhile engaged in lawsuits with a variety of other companies in the microarray arena over its patent estate. For more information, see the current issue of BioArray News.



The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.